Another mutation that results in the substitution ...[Hum Mol Genet. 1995] - PubMed Result

SearchDatabase nameforSearch term

Advanced Search

Your browser version may not work well with NCBI's Web applications. More information here...

Display Show

All: 1

Review: 0

Click to change filter selection through MyNCBI.

1: Hum Mol Genet. 1995 Nov;4(11):2175-7. Links

Another mutation that results in the substitution of an unpaired cysteine residue in the extracellular domain of FGFR3 in thanatophoric dysplasia type I.

Tavormina PL, Rimoin DL, Cohn DH, Zhu YZ, Shiang R, Wasmuth JJ.

Department of Biological Chemistry, University of California, Irvine 92717, USA.

PMID: 8589699 [PubMed - indexed for MEDLINE]

Related Articles

Mutations in the fibroblast growth factor receptor 3 (FGFR3) cause achondroplasia, hypochondroplasia, and thanatophoric dysplasia: Taiwanese data. [Am J Med Genet. 1999]
Thanatophoric dysplasia (types I and II) caused by distinct mutations in fibroblast growth factor receptor 3. [Nat Genet. 1995]
Differential activation of cysteine-substitution mutants of fibroblast growth factor receptor 3 is determined by cysteine localization. [J Bone Miner Res. 2002]
ReviewFibroblast growth factor receptor 3 and the human chondrodysplasias. [Curr Opin Pediatr. 1997]
Review[From gene to disease; achondroplasia and other skeletal dysplasias due to an activating mutation in the fibroblast growth factor] [Ned Tijdschr Geneeskd. 2001]

|

Display Show